"Antigen-Specific Immune Tolerance Technology"
CEO: John Seman

University at Buffalo, The State University of New York
Startup Officer: Brian McIlroy

Technology Area: 
  • Pharmaceuticals and Medical

Website: http://www.zoeticpharmaceuticals.com/
ZOETIC Pharmaceuticals, Inc. (ZPI) is an early stage company advancing proprietary phospholipid based nanoparticle technology that has been shown to reduce the immunogenicity of therapeutic proteins, has the potential to treat autoimmune diseases, and offers an immune tolerance approach to improving the success of gene therapy.
Articles to be posted soon.